These symptoms typically occur during treatment initiation or dose escalation and often improve over several weeks as the body adapts
According to the Wegovy (semaglutide 2.4 mg) label, alopecia was reported in 3.5% of patients versus 1.0% on placebo
Zhi W, Li K, Wang H, Lei M, Guo Y
We include detailed case examples, relevant statistics (utilization, cost, approval rates), and expert commentary
The duration of GLP-1 weight loss treatment varies by patient due to health profile, metabolism, desired weight loss goals, adherence to related diet and exercise plans, and the potential need to manage weight-related comorbidities
Reduced insulin resistance Insulin is a vital hormone in your body and involved in blood sugar control